the aid library

LIST OPTIONS

Filter

9078

National Guidelines for Integrated Diseases Surveillance and Response Uganda

World Health Organization WHO, Regional Office of Africa; Ministry of Health Uganda (2021) C_WHO

3rd edition. In 2001, Uganda adapted the Integrated Disease Surveillance and Response (IDSR) developed by World Health Organization (WHO) for member states in African region. The Ministry of Health has been implementing the IDSR strategy since then with success across the country. This strategy prov... more

Download (251)

View PDF (428)

Pediatric oncology nursing practice in Latin America and the Caribbean

Pan American Health Organisation PAHO (2024) C_WHO

One of the main aims of the WHO Global Initiative for Childhood Cancer and the CureAll Americas framework is to strengthen centers of excellence and promote the training of the health workforce, especially pediatric oncology nurses, specialized in nursing care for children and adolescents with cance... more

External Link

Six I’s HIV/TB Communication and Advocacy Toolkit

AIDS and Rights Alliance for Southern Africa (ARASA) (2017) CC

Please download the complete toolkit directly from the website (large size: 24 MB)

Download (471)

View PDF (697)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

External Link

Communicable disease surveillance and response systems

World Health Organization (2006)

Guide to monitoring and evaluating

Download (595)

View PDF (867)

India: Guidelines for the Public Private Partnership Model of ART centres

National AIDS Control Organisation (NACO), Government of India (2017) C1

Download (1073)

View PDF (2874)

Training Course on the Management of Severe Malnutrition Course Director Guide

WHO WHO (2002)

Download (1370)

View PDF (3248)

Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India + Annexures

Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare (2012) C1

Download (338)

View PDF (490)

Improving Prison Conditions by Strengthening the Monitoring of HIV, HCV, TB and Harm Reduction (Portugal)

N. H. Ponters, A. P. Dores CIES IUL; ISCTE IUL; European Union (2015) C2

Mapping Report - Portugal

Download (1378)

View PDF (2540)

Reproductive Health Assessment Toolkit for Conflict-Affected Women (Cover)

Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Coordinating Center for Health Promotion, Centers for Disease Control and Prevention, Department of Health and Human Services, (2007)

This is only the cover of the book. Download the whole Toolkit at: www.cdc.gov/reproductivehealth/Refugee/ Understanding the reproductive health needs of conflict-affected women will enable organizations to implement and enhance programs and services to improve the health of women and their fam... more

Download (602)

View PDF (775)

Epidemic meningitis surveillance in the African meningitis belt

World Health Organization WHO (2014) C_WHO

Download (970)

View PDF (2824)

Building the legacy of Ebola: Survivors, health systems, and a blueprint for research and development

World Health Organization WHO (2017) C_WHO

This report describes the work done by WHO from January 2015 up to the end of December 2016 to address the long-term issues of survivor care, health-systems strengthening and research.

Download (647)

View PDF (984)

Key considerations: the context of North Kivu province, DRC

Social Science in Humanitarian Action: A Communication for Development Platform (2018) C1

This brief focuses specifically on the Grand Nord (Great North): the Beni and Lubero territories of northern North Kivu that are the epicentre of the outbreak. Further participatory enquiry should be undertaken with the affected populations, but given ongoing transmission, conveying key consideratio... more

Download (498)

View PDF (734)

Humanitarian inclusion standards for older people and people with disabilities
recommended

Age and Disability Consortium CBM International, HelpAge International,and Handicap International (2018)

The Standard consists of nine key inclusion standards, and seven sets of sector-specific inclusion standards for protection – water, sanitation and hygiene, food security and livelihoods, nutrition, shelter, settlement and household items, health and education. Each standard comes with key actions... more

Download (1104)

View PDF (2386)

Technical note for Ebola virus disease preparedness planning for entry screening at airports, ports and land crossings

World Health Organization (2014)

Download (287)

View PDF (406)

Strategic Considerations for Mitigating the Impact of COVID-19 on Key Population-Focused HIV Programs

FHI 360; UNAIDS reliefweb (2020) C2

The COVID-19 pandemic has affected everyone, including key populations at higher risk of HIV. And the gains made against other infectious diseases, including HIV, are at risk of being reversed as a result of disruptions caused by COVID-19. This is the background to a new report published by FHI 360,... more

Download (372)

View PDF (429)

Rules of engagement between the UN and private actors - Towards a regulatory and institutional framework

Jens Martens and Karolin Seitz MSEREOR, Brot für die Welt, Global Policy Forum Europe (2019) C2

This working paper aims to provide a rough over-view of existing rules and guidelines on the coopera-tion between the UN and the private sector – at least as they are publicly available. It will describe com-mon features and discuss advances and shortcomings of the most prominent a... more

Download (554)

View PDF (766)

Handbook for Coordinating Gender-based Violence Interventions in Emergencies 2019
recommended

Protection Cluster (2019) C2

This handbook is a quick-reference tool that provides practical, field-level guidance to establish and maintain a GBV sub-cluster in a humanitarian emergency. It provides the foundations for coordination. More in-depth information can be pursued through resources referenced in this handbook. The GBV... more

External Link

"Shadow" Report - Healthcare Field - Case of Albania

Albanian Center for Population and Development (ACPD); UNFPA (2016) C2

Submitted to the United Nation's Committee on the Convention on the Elimination of All Forms of Discrimination Against Women February 2016 Published by the Albanian Center for Population and Development (ACPD) Adresa : Bul “ Gjergj Fishta”, Kompleksi “Tirana 2000” Kulla 4, kati 2, Tir... more

Download (499)

View PDF (924)

Manual on Cyclone: Causes, Effects & Preparedness

The Republic of the Union of Myanmar, Relief and Resettlement Department; UN-Habitat (2010) C1

No publication year indicated.

Humanitarian inclusion standards for older people and people with disabilities recommended

Handbook for Coordinating Gender-based Violence Interventions in Emergencies 2019 recommended

Humanitarian inclusion standards for older people and people with disabilities
recommended

Handbook for Coordinating Gender-based Violence Interventions in Emergencies 2019
recommended